| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 523 |
| 1 | APIXABAN | 348 |
| 2 | ASPIRIN | 325 |
| 3 | ASPIRIN 325 MG | 309 |
| 4 | ASPIRIN 81 MG | 309 |
| 5 | DABIGATRAN ETEXILATE | 275 |
| 6 | DABIGATRAN ETEXILATE MESYLATE | 231 |
| 7 | FUROSEMIDE | 204 |
| 8 | CLOPIDOGREL | 185 |
| 9 | METOPROLOL TARTRATE | 144 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BIVALIRUDIN | 8 | 0.0081 |
| 1 | TETRACAINE HYDROCHLORIDE | 1 | 0.0075 |
| 2 | TENECTEPLASE | 11 | 0.0069 |
| 3 | EPTIFIBATIDE | 5 | 0.0065 |
| 4 | IDARUCIZUMAB | 9 | 0.0063 |
| 5 | THROMBIN HUMAN AND FIBRINOGEN | 2 | 0.0060 |
| 6 | ARGATROBAN | 8 | 0.0053 |
| 7 | APIXABAN | 348 | 0.0051 |
| 8 | CANGRELOR | 2 | 0.0050 |
| 9 | DABIGATRAN ETEXILATE | 275 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 854 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 409 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 331 |
| 3 | Loop Diuretic [EPC] | 216 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 159 |
| 5 | beta-Adrenergic Blocker [EPC] | 120 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 119 |
| 7 | Proton Pump Inhibitor [EPC] | 119 |
| 8 | Calcium Channel Blocker [EPC] | 108 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 105 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 9 | 0.0063 |
| 1 | Anti-coagulant [EPC] | 15 | 0.0040 |
| 2 | Factor Xa Inhibitor [EPC] | 854 | 0.0031 |
| 3 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 4 | Glinide [EPC] | 18 | 0.0020 |
| 5 | Alkaloid [EPC] | 50 | 0.0019 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 7 | P2Y12 Platelet Inhibitor [EPC] | 159 | 0.0013 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 7 | 0.0011 |
| 9 | Lipopeptide Antibacterial [EPC] | 9 | 0.0009 |